Hepatotoxicity induced by fosinopri [2]

Journal of Hepatology

Volumn 35, Issue 2, 2001, Pages 309-310

  Romero Gómez, Manuel ^a   Miralles, Edmundo Juan ^a   García Díaz, Enrique ^a   Robles, Antonio ^a   Suárez, Emilio ^a   Castro, Manuel ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIHYPERTENSIVE AGENT; ASPARTATE AMINOTRANSFERASE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ALCOHOL CONSUMPTION; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LETTER; LIVER FUNCTION TEST; LIVER TOXICITY; PRIORITY JOURNAL; ADULT; ALCOHOLISM; FEMALE; MALE; PATHOLOGY; TOXIC HEPATITIS;

ADULT; ALCOHOLISM; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; FEMALE; FOSINOPRIL; HEPATITIS, TOXIC; HUMANS; MALE;

EID: 0034741945     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00098-8     Document Type: Letter

References (8)

1. Criteria of drug-induced liver disorders. Report of an international consensus meeting
2. Study of the efficacy and safety of fosinopril in general practice in 19435 hypertensive patients
3. Fosinopril national survey: A post-marketing surveillance study of fosinopril in general practice in the UK
4. Enalapril-induced hepatotoxicity
5. Captopril-associated 'pseudocholangitis'. A case and review of the literature
6. Hepatotoxicity associated with angiotensin converting enzyme inhibitors
7. Fulminant hepatitis after lisinopril administration
8. Comparative cytotoxicity of angiotensin-converting enzyme inhibitors in cultured rat hepatotocytes